Ulcerative colitis
Conditions
Interventions
Group A:Mesalazine combined with placebo
Group B:Methalazine combined with probiotics
Group C:Probiotics combined with placebo
Normal control group:Blank control
Sponsors
Affiliated Hospital of Inner Mongolia Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Meet the standard of diagnosis of UC patients with 2012 Chinese Medical Association digestive disease credits for inflammatory bowel disease treatment group developed "China's diagnosis and treatment of inflammatory bowel disease consensus opinion"; 2. All patients with UC were staged and graded according to the "modified Mayo scoring system for assessing the activity of ulcerative colitis." Patients with mild to moderate UC were selected; 3. Informed consent was obtained from all participants in the study.
Exclusion criteria
Exclusion criteria: (1) Age <18 years; (2) The past 4 weeks using microbial agents, antibiotics, glucocorticoids, immunosuppressive agents; (3) A history of abdominal surgery; (4) Cardiovascular, respiratory, kidney, blood, endocrine and other serious diseases of the system; (5) Severe UC patients and can not rule out the possibility of cancer; (6) There are serious complications or coexistence of other causes of intestinal diseases are clear; (7) Pregnant women and lactating women; (8) If the specimen is contaminated, or if there is insufficient specimen retention.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Microbial door, genus, species relative content; | — |
Countries
China
Contacts
Public ContactChen Ping
Affiliated Hospital of Inner Mongolia Medical University
Outcome results
None listed